- On the basis of its move to a direct distribution model, Chembio Diagnostics ((CEMI) +.4%) terminates its U.S. STAT-PAK distribution agreement with Alere (ALR +1.3%) (formerly Inverness Medical Innovations).
- Alere had the rights since 2006 to sell the firm's STAT-PAK HIV assays in the U.S. under its Clearview brand.
- CEMI is currently in the midst of a sales force build out.
Diagnostics firm changes U.S. distribution
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs